This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Drug-induced aseptic meningitis (DIAM) may be difficult to differentiate from bacterial meningitis or from manifestations of the underlying disease.1,2 We report a patient with recurrent ibuprofen-induced aseptic meningitis, whose history suggests an antigen-specific T-cell mechanism.
Case report.
A 55-year-old man began a treatment of ibuprofen for osteoarthritis of the hip. After 3 months of nonspecific flu-like symptoms and muscle pain, he presented with an acute onset of headache, fever, meningism, and dizziness. CSF analysis disclosed an enhanced cell count (145 cells/mm3, predominantly polymorphonuclear cells and macrophages), enhanced proteinorachia (1,230 mg/L), but a normal glucose level. Blood and CSF cultures, viral serologies, and antinuclear factor were negative. Symptoms improved after ibuprofen was stopped. Subsequently the patient occasionally took aspirin and mefenamic acid without any adverse effect. A follow-up CSF analysis was normal. Nine months later, a single dose of 600 mg ibuprofen was administered, and within 90 minutes, the patient presented with fever, chills, headache, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
